12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Kcentra regulatory update

CSL said the Centers for Medicare and Medicaid Services (CMS) will provide hospitals with additional reimbursement payments beyond the predetermined standard rates for the use of Kcentra in an inpatient setting for the urgent reversal of warfarin therapy in adults with acute major bleeding....

Read the full 198 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >